[Efficacy and safety of non-immunogenic staphylokinase in the ischemic stroke in real-world clinical practice in the Sverdlovsk region].
A M AlasheevE V LantsovaD A TretyakovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The comparable efficacy and safety of Fortelysine and alteplase in IS has been proven in clinical study and confirmed by real-world clinical practice.